US FDA approves GSK's combo meningococcal vaccine
The U.S. Food and Drug Administration approved British drugmaker GSK's combination vaccine to protect against meningococcal ...
This under-the-radar software company could be one of the UK’s finest growth stocks
Hidden beneath the FTSE 100 and the FTSE 250, Stephen Wright thinks there are some outstanding growth stocks for UK investors to take a look at.
pharmaphorum18h
GSK says $2.2bn settlement resolves most Zantac litigation
GSK has reached an agreement that it says will resolve 93% of the outstanding lawsuits brought against the company claiming that its gastrointestinal drug Zantac caused cancer. The company has ...